Advertisement
CORRESPONDENCE|Articles in Press

Sclerosing odontogenic carcinoma with local recurrence and lymph node metastasis

      To the Editor,
      Sclerosing odontogenic carcinoma (SOC) is very rare. Moreover, it was only formally adopted in the 4th edition of the World Health Organization (WHO) classification of head and neck tumours in 2017.
      • Odell E.W.
      • Koutlas I.
      Sclerosing odontogenic carcinoma.
      SOC is a locally aggressive low grade malignancy primarily diagnosed based on its microscopic appearance (i.e., skeletal muscle invasion or perineural infiltration).
      • Odell E.W.
      • Koutlas I.
      Sclerosing odontogenic carcinoma.
      However, the scarcity of reported cases (less than 15) precludes malignancy grading.
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      • Soluk-Tekkesin M.
      • Wright J.M.
      The World Health Organization Classification of odontogenic lesions: a summary of the changes of the 2022 5th ed.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      The consensus among modern pathologists is that SOC has no metastatic potential,
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      ,
      • Soluk-Tekkesin M.
      • Wright J.M.
      The World Health Organization Classification of odontogenic lesions: a summary of the changes of the 2022 5th ed.
      which was added to the SOC definition in the 5th edition of the WHO classification of head and neck tumours, available online in 2022.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      Nevertheless, the true malignant nature of SOC remains controversial because reports on metastasis are lacking.
      • Odell E.W.
      • Koutlas I.
      Sclerosing odontogenic carcinoma.
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      • Soluk-Tekkesin M.
      • Wright J.M.
      The World Health Organization Classification of odontogenic lesions: a summary of the changes of the 2022 5th ed.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      • Ide F.
      • Ito Y.
      • Muramatsu T.
      • et al.
      Sclerosing odontogenic carcinoma: a morphologic pattern or pathologic entity?.
      Herein, we describe a case of SOC with solitary lymph node metastasis. Such biological behaviour has never been documented.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      Therefore, this case provides undeniable evidence that SOC metastases are possible.
      A 41-year-old woman presented with diffuse swelling of the left mandible. Clinical examinations showed a hard buccal expansion of the body of the mandible. Furthermore, axial post-contrast computed tomography (CT) revealed a heterogeneously enhanced space-occupying mass in the left mandible with the destruction of the buccal and lingual cortices (Fig. 1A). Thus, invasive growth into the masseter and mylohyoid muscles was highly suspected. Additionally, a neighbouring submandibular lymph node was enlarged (Fig. 1B), and a small superficial biopsy was interpreted as ‘features consistent with desmoplastic fibroma’. Therefore, a hemimandibulectomy with excision of an enlarged lymph node was performed. The surgical specimen was solid and hard, with an ill-defined tumour in the mandible measuring 6.0×4.5×3.3 cm (Fig. 1C).
      Fig. 1
      Fig. 1(A) Axial and (B) coronal post-contrast computed tomography images showing enlargement of the submandibular lymph node (arrows) near the tumour (arrowheads) and submandibular gland (∗). (C) Gross appearance of the solid tumour. (D) Thin tumour cords compressed by sclerotic stroma. (E) Clear tumour cells. (F) Immunopositivity for cytokeratin (CK) 5/6. (G) Lymph node metastasis highlighted by CK5/6. Inset: tubular formation.
      Histologically, the lesion was composed of scirrhous fibrous tissue in which small strands and islands of tumour cells were often difficult to discern. There were single-file thin cords of inactive looking odontogenic epithelium, and these cells were cuboidal or polygonal shaped with bland nuclear features (Fig. 1D). The mitotic figures were inconspicuous throughout the tumour. In the focal areas, scattered clear cells were observed (Fig. 1E), and they were unreactive with the periodic acid–Schiff staining.
      Immunohistochemically, the tumour cells were highlighted by their diffuse and intense positivity for cytokeratin (CK) 5/6 (Fig. 1F), p40, p63, and CK19, but AE1/AE3 expression was variable. The average Ki-67 labelling index was approximately 15.9% in the highest part. Scattered epithelial clusters were observed in an extirpated lymph node; all were strongly positive for CK5/6 (Fig. 1G). Notably, several metastatic tumour nests formed the tubuloductal epithelial structures. Therefore, we diagnosed the patient with SOC with lymph node metastasis based on the overall findings.
      One year after the mandibulectomy, reconstructive surgery was performed. Later, the patient was closely followed, and local recurrence was identified 3 years later. A CT examination revealed cortical expansion and destruction of the mandibular symphysis. Furthermore, a recurrent tumour occupied the left infratemporal fossa (Fig. 2A,B), which was confirmed by coronal post-contrast fat-suppressed T1-weighted imaging (Fig. 2C). The recurrent tumour was resected at another institution, and chemo-radiotherapy was administered because of positive margins. Currently, the patient is in clinical remission.
      Fig. 2
      Fig. 2(A) Axial bone algorithm computed tomography (CT) image showing recurrence (arrows). (B) Axial non-contrast-enhanced soft tissue algorithm CT image showing infratemporal fossa involvement (∗). (C) Coronal post-contrast fat-suppressed T1-weighted image with abnormal enhancement in the orifice of the foramen ovale, suggesting perineural invasion (arrow). (D) Recurrent sclerosing odontogenic carcinoma with a densely collagenous stroma. (E) Reticular growth pattern. (F) Larger tumour nests. (G) Tumour cells encircling two peripheral nerves. (H) P63 expression.
      In the recurrent tumour, the histopathology essentially matched that of the primary SOC (Fig. 2D). However, some compressed tumour cells exhibited a unique reticular growth pattern (Fig. 2E), and the solid SOC nests were slightly larger. They lacked overt squamous and ameloblastic differentiation (Fig. 2F). As expected, we observed considerable perineural infiltration (Fig. 2G). Unlike the primary lesion, spindle cell proliferation, necrotic tumour nests, and myxoid stroma, although focal, were evident. Immunohistochemical evaluation revealed an identical phenotype to the primary and metastatic SOCs (Fig. 2H). In additional sections, the tumour expanded extensively to involve surrounding tissue (Fig. 3A), and there were multiple infiltrating nests of clear cells in a very dense collagenous stroma (Fig. 3B). To verify the diagnosis, fluorescence in situ hybridisation (FISH) analysis was performed to investigate a rearrangement of the EWSR1 gene. There was no evidence of either a EWSR1 split or EWSR1-ATF1 gene fusion in any of the primary and recurrent tumours, consistent with the diagnosis of SOC.
      Fig. 3
      Fig. 3The recurrent tumour. (A) Unquestionable infiltration into perineural (arrow) and perivascular (arrowhead) tissues. (B) Small clustered and single clear cells embedded in a hyalinised stroma.
      Currently, SOC is defined as a low grade carcinoma with no metastatic potential.
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      • Soluk-Tekkesin M.
      • Wright J.M.
      The World Health Organization Classification of odontogenic lesions: a summary of the changes of the 2022 5th ed.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      However, it has become increasingly clear from the reported SOC cases that a malignant character is not always evident in the clinical setting.
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      The histological differential diagnosis of SOC is challenging in almost all cases.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      Without cytological atypia, focal invasion into surrounding bone and muscle or intra- or peri-neural infiltration is the only criterion for diagnosing SOC as carcinoma.
      • Odell E.W.
      • Koutlas I.
      Sclerosing odontogenic carcinoma.
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      • Soluk-Tekkesin M.
      • Wright J.M.
      The World Health Organization Classification of odontogenic lesions: a summary of the changes of the 2022 5th ed.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      • Ide F.
      • Ito Y.
      • Muramatsu T.
      • et al.
      Sclerosing odontogenic carcinoma: a morphologic pattern or pathologic entity?.
      Given the presence of clear tumour cells in our case, we performed a FISH molecular genetic study for EWSR1 arrangement characteristic of clear cell odontogenic carcinoma.
      • Odell E.W.
      • Koutlas I.
      Sclerosing odontogenic carcinoma.
      ,
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      ,
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      This was negative in the present lesion, as in other reported cases of SOC.
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      ,
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      ,
      • Todorovic E.
      • Berthelet E.
      • O'Connor R.
      • et al.
      Sclerosing odontogenic carcinoma with local recurrence: case report and review of literature.
      • Seki-Soda M.
      • Sano T.
      • Ogawa I.
      • et al.
      Two cases of odontogenic carcinoma with sclerosing features in the mandible: diagnostic difficulties in a sclerosing odontogenic carcinoma.
      • Seyiti P.
      • Feng Y.
      • Gao A.
      • et al.
      An extensive sclerosing odontogenic carcinoma in mandible: a case report and literature review.
      Besides the usual clear cell population, SOC can display unusual histomorphological patterns, including squamous differentiation, spindle cell foci, or ameloblastoma-like nests.
      • Todorovic E.
      • Berthelet E.
      • O'Connor R.
      • et al.
      Sclerosing odontogenic carcinoma with local recurrence: case report and review of literature.
      ,
      • Seki-Soda M.
      • Sano T.
      • Ogawa I.
      • et al.
      Two cases of odontogenic carcinoma with sclerosing features in the mandible: diagnostic difficulties in a sclerosing odontogenic carcinoma.
      ,
      • Hanisch M.
      • Baumhoer D.
      • Elges S.
      • et al.
      Sclerosing odontogenic carcinoma: current diagnostic and management considerations concerning a most unusual neoplasm.
      In the 2022 WHO classification, there was a brief comment that SOC may have infrequent islands of more epidermoid cells.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      The lesion presented in this study showed a reticular arrangement of tumour cells, which has not been previously described.
      • Odell E.W.
      • Koutlas I.
      Sclerosing odontogenic carcinoma.
      ,
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      ,
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      However, a nasopharyngeal squamous cell carcinoma case report described this unique growth pattern using the diagnostic terminology ‘reticular non-keratinising carcinoma’.
      • Petersson F.
      • Vijayadwaja D.
      • Loh K.S.
      • et al.
      Reticular and myxoid non-keratinizing nasopharyngeal carcinoma: an unusual case mimicking a salivary gland carcinoma.
      The SOC tumour in our case also expressed CK5/6, p40, and p63; thus, SOC may be a form of primary intraosseous non-keratinising squamous cell carcinoma.
      Recently, Koutlas et al.
      • Koutlas I.G.
      • Ponce K.J.
      • Wazen R.M.
      • et al.
      An unusual maxillary tumor with tubuloductal epithelial structures, solid epithelial nests and stromal odontogenic ameloblast-associated protein deposits. Tubuloductal/syringoid variant of central odontogenic fibroma with amyloid?.
      observed many duct-like epithelial structures in an amyloid variant of central odontogenic fibroma, suggesting ductal differentiation of neoplastic odontogenic epithelium. Evaluations of the lymph node metastasis in this study identified apparent tubular formation in the tumour nests, which has also been reported in at least three other cases.
      • Lim D.
      • Tan C.C.
      • Tilakaratne W.M.
      • et al.
      Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
      The 2022 WHO classification clearly described that glandular differentiation may be seen in SOC.
      • Koutlas I.G.
      Sclerosing odontogenic carcinoma.
      These observations support the odontogenic origin of SOC and also imply a histogenetic kinship between SOC and central odontogenic fibroma.
      • Tosios K.I.
      • Giannoulis G.
      • Kaklamanis L.
      • et al.
      A central maxillary tumor with bland cytology, partly sclerotic stroma, and neural involvement. Scleroing odontogenic carcinoma or epithelial neurotropism in an odontogenic fibroma?.
      In summary, we report the first case of SOC with recurrence and metastasis. The latter finding emphasises that SOC can be truly malignant. Therefore, awareness of the metastatic potential of SOC is essential in clinical practice. Furthermore, pathologists should be aware that the microscopic features of SOC significantly vary in the literature, from central odontogenic fibroma to clear cell odontogenic carcinoma, ameloblastic carcinoma or primary intraosseous carcinoma, not otherwise specified.

      Acknowledgements

      We greatly thank Dr Rie Ohtomo and Dr Hirokazu Taniguchi of the Department of Clinical Laboratory, JR Tokyo General Hospital, for providing surgical specimens of a recurrent tumour; we would like to express our sincere gratitude to Dr Yukiko Sato and Dr Kengo Takeuchi of the Department of Pathology, Cancer Institute Hospital, for their significant contribution to molecular analyses. We also thank Editage (www.editage.com) for English language editing.

      Conflicts of interest and sources of funding

      This work was partially supported by research grants from the Sato Fund of the Nihon University School of Dentistry and by a grant from the Dental Research Center of the Nihon University School of Dentistry. The authors state that there are no conflicts of interest to disclosure.

      References

        • Odell E.W.
        • Koutlas I.
        Sclerosing odontogenic carcinoma.
        in: El-Naggar A.K. Chan J.K.C. Grandis J.R. WHO Classification of Head and Neck Tumours. 4th ed. IARC, Lyon2017: 209-210
        • Lim D.
        • Tan C.C.
        • Tilakaratne W.M.
        • et al.
        Sclerosing odontogenic carcinoma - review of all published cases: is it a justifiable addition as a malignancy?.
        Braz J Otorhinolaryngol. 2022; 88: 118-129
        • Soluk-Tekkesin M.
        • Wright J.M.
        The World Health Organization Classification of odontogenic lesions: a summary of the changes of the 2022 5th ed.
        Turk J Pathol. 2022; 38: 168-184
        • Koutlas I.G.
        Sclerosing odontogenic carcinoma.
        in: WHO Classification of Tumours Editorial Board. Head and Neck Tumours. 5th ed. IARC, Lyon2022 (online; beta version ahead of print)
        • Ide F.
        • Ito Y.
        • Muramatsu T.
        • et al.
        Sclerosing odontogenic carcinoma: a morphologic pattern or pathologic entity?.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 115: 839
        • Todorovic E.
        • Berthelet E.
        • O'Connor R.
        • et al.
        Sclerosing odontogenic carcinoma with local recurrence: case report and review of literature.
        Head Neck Pathol. 2019; 13: 371-377
        • Seki-Soda M.
        • Sano T.
        • Ogawa I.
        • et al.
        Two cases of odontogenic carcinoma with sclerosing features in the mandible: diagnostic difficulties in a sclerosing odontogenic carcinoma.
        J Oral Maxillofac Surg Med Pathol. 2020; 32: 149-155
        • Seyiti P.
        • Feng Y.
        • Gao A.
        • et al.
        An extensive sclerosing odontogenic carcinoma in mandible: a case report and literature review.
        Dentomaxillofac Radiol. 2020; 4920190426
        • Hanisch M.
        • Baumhoer D.
        • Elges S.
        • et al.
        Sclerosing odontogenic carcinoma: current diagnostic and management considerations concerning a most unusual neoplasm.
        Int J Oral Maxillofac Surg. 2017; 46: 1641-1649
        • Petersson F.
        • Vijayadwaja D.
        • Loh K.S.
        • et al.
        Reticular and myxoid non-keratinizing nasopharyngeal carcinoma: an unusual case mimicking a salivary gland carcinoma.
        Head Neck Pathol. 2014; 8: 364-368
        • Koutlas I.G.
        • Ponce K.J.
        • Wazen R.M.
        • et al.
        An unusual maxillary tumor with tubuloductal epithelial structures, solid epithelial nests and stromal odontogenic ameloblast-associated protein deposits. Tubuloductal/syringoid variant of central odontogenic fibroma with amyloid?.
        Head Neck Pathol. 2022; 16: 587-595
        • Tosios K.I.
        • Giannoulis G.
        • Kaklamanis L.
        • et al.
        A central maxillary tumor with bland cytology, partly sclerotic stroma, and neural involvement. Scleroing odontogenic carcinoma or epithelial neurotropism in an odontogenic fibroma?.
        Oral Surg. 2022; 15: 624-629